These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 34582263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 10. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.
    Paken J, Govender CD, Sewram V.
    BMC Womens Health; 2017 Dec 11; 17(1):129. PubMed ID: 29228931
    [Abstract] [Full Text] [Related]

  • 11. Insight into the current practice of ototoxicity monitoring during cisplatin therapy.
    Santucci NM, Garber B, Ivory R, Kuhn MA, Stephen M, Aizenberg D.
    J Otolaryngol Head Neck Surg; 2021 Mar 25; 50(1):19. PubMed ID: 33766142
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.
    Konrad-Martin D, James KE, Gordon JS, Reavis KM, Phillips DS, Bratt GW, Fausti SA.
    J Am Acad Audiol; 2010 May 25; 21(5):301-14; quiz 357. PubMed ID: 20569665
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.
    Sriyapai T, Thongyai K, Phuakpet K, Vathana N, Buaboonnam J, Sanpakit K.
    Turk J Pediatr; 2022 May 25; 64(3):531-541. PubMed ID: 35899566
    [Abstract] [Full Text] [Related]

  • 15. Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center.
    Gambacorta V, Orzan E, Faralli M, Gullà M, Lapenna R, Baietta I, De Angelis V, Ricci G.
    Audiol Res; 2023 Oct 18; 13(5):779-790. PubMed ID: 37887850
    [Abstract] [Full Text] [Related]

  • 16. Is Methotrexate Ototoxic? Investigating the Ototoxic Late Effects of Pediatric Cancer Treatment.
    Moore B, Sheets G, Doss J, Umrigar A, Norman M, Fang Z, Prasad P, Musso A, Clay S, Tsien F.
    Am J Audiol; 2023 Sep 06; 32(3):657-664. PubMed ID: 37532243
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.
    Garinis AC, Cornell A, Allada G, Fennelly KP, Maggiore RJ, Konrad-Martin D.
    Int J Audiol; 2018 Sep 06; 57(sup4):S19-S24. PubMed ID: 28978238
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.